Xinhua Li

Clear Scientific, LLC

NIH Rank #431
  • Program Leader
  • Top 5% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$8.6M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#431
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $8.6M across 3 grants · National rank #431.

Top grants by award amount

Xinhua Li's NIH grant portfolio, ranked by award amount.

  • 5U01DA058548-02U01
    Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication
    $4.1M
    award amount
  • 5UG3DA059286-02UG3
    A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body
    $3.1M
    award amount
  • 2R44DA056272-02R44
    A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine
    $1.5M
    award amount

Affiliation

Institutions that have administered grants for Xinhua Li.

Affiliated with Clear Scientific, LLC (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Clear Scientific, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #431
  7. 2024
    Entered Top 25% Nationally
    Ranked #431
  8. 2024
    Entered Top 10% Nationally
    Ranked #431
  9. 2024
    Entered Top 5% Nationally
    Ranked #431